Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tivic Health Systems, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TIVC
Nasdaq
3840
tivichealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tivic Health Systems, Inc.
Tivic Expands Intellectual Property Portfolio
- Nov 10th, 2025 7:00 am
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
- Nov 6th, 2025 7:30 am
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
- Oct 22nd, 2025 12:00 pm
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
- Sep 24th, 2025 5:00 am
Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference
- Sep 22nd, 2025 6:30 am
Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing
- Sep 10th, 2025 6:30 am
Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
- Aug 20th, 2025 6:30 am
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
- Aug 15th, 2025 6:30 am
Tivic Reports Second Quarter 2025 Financial Results
- Aug 14th, 2025 2:00 pm
Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast
- Aug 7th, 2025 6:30 am
Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO
- Jul 8th, 2025 6:30 am
Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
- Jun 25th, 2025 6:30 am
Tivic Health Announces 2025 Annual Meeting of Stockholders
- Jun 24th, 2025 6:30 am
Life Sciences Investor Forum: Now Available for Online Viewing
- Jun 13th, 2025 6:35 am
Life Sciences Investor Forum Agenda Announced for June 11th-12th
- Jun 10th, 2025 12:38 pm
Sidoti Events, LLC's Virtual May Micro-Cap Conference
- May 20th, 2025 6:00 am
Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation
- May 15th, 2025 2:05 pm
Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
- May 14th, 2025 6:30 am
Tivic Expands VNS Intellectual Property Portfolio
- May 13th, 2025 6:30 am
Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast
- May 9th, 2025 6:30 am
Scroll